Activation of Cardiac δ2-Opioid Receptors Increases Heart Tolerance to Reperfusion

Bull Exp Biol Med. 2024 Mar;176(5):539-542. doi: 10.1007/s10517-024-06063-6. Epub 2024 May 8.

Abstract

Coronary occlusion (45 min) and reperfusion (120 min) in male Wistar rats in vivo, as well as total ischemia (45 min) of an isolated rat heart followed by reperfusion (30 min) were reproduced. The selective δ2-opioid receptor agonist deltorphin II (0.12 mg/kg and 152 nmol/liter) was administered intravenously 5 min before reperfusion in vivo or added to the perfusion solution at the beginning of reperfusion of the isolated heart. The peripheral opioid receptor antagonist naloxone methiodide and δ2-opioid receptor antagonist naltriben were used in doses of 5 and 0.3 mg/kg, respectively. It was found that the infarct-limiting effect of deltorphin II is associated with the activation of δ2-opioid receptors. We have demonstrated that deltorphin II can improve the recovery of the contractility of the isolated heart after total ischemia.

Keywords: heart; opioid receptors; reperfusion.

MeSH terms

  • Animals
  • Heart / drug effects
  • Male
  • Myocardial Contraction / drug effects
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / metabolism
  • Myocardial Infarction / physiopathology
  • Myocardial Reperfusion Injury* / metabolism
  • Myocardial Reperfusion Injury* / physiopathology
  • Myocardium / metabolism
  • Narcotic Antagonists / pharmacology
  • Oligopeptides / pharmacology
  • Rats
  • Rats, Wistar*
  • Receptors, Opioid, delta* / agonists
  • Receptors, Opioid, delta* / metabolism

Substances

  • deltorphin